ABSORICA LD
Identification of Absorica Ld
| No description |
Google image searchProduct monograph
Active ingredient
isotretinoin, 8 MG
DIN: 02539047
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Date: 26-SEP-2023
ATC:
- D10 — ANTI-ACNE PREPARATIONS (ATC, ATC/DDD, )
- D10B — ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE (ATC, ATC/DDD)
- D10BA — Retinoids for treatment of acne (ATC, ATC/DDD)
- D10BA01 — ISOTRETINOIN (ATC/DDD)
Reference brand drug: Accutane, Epuris
Pharmaceutical standard: USP
